Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISHL HL Update 2021 | Inferior outcomes seen in elderly patients with HL

Jonathan Friedberg • 11 Mar 2021
ISHL HL Update 2021
Hodgkin Lymphoma Lymphoma

Jonathan Friedberg, MD, University of Rochester, Rochester, NY, explores why elderly patients with Hodgkin lymphoma (HL) demonstrate inferior outcomes, including comorbidities that limit the ability to give standard treatment, as well as the complex form of Hodgkin lymphoma seen in older patients. This interview took place at the Update on Hodgkin Lymphoma 2021, a Virtual ISHL event.

More from Jonathan Friedberg

2:20
Nivolumab-AVD vs brentuximab vedotin-AVD in pediatric patients with cHL: SWOG S1826 trial
Jonathan Friedberg • 10 Dec 2023
2:10
ILyAD study: vitamin D supplementation in low tumor-burden indolent NHL treated with rituximab
Jonathan Friedberg • 10 Dec 2023
2:52
Elderly patients with HL: unmet needs and promising strategies
Jonathan Friedberg • 6 Sep 2023
1:27
Classifying frailty in patients with Hodgkin lymphoma
Jonathan Friedberg • 6 Sep 2023

Related Videos

3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
2:11
The role of CAR-T therapy for lymphoma in 2024: expert session highlights
Sridhar Chaganti • 16 Apr 2024
1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals